13F
← All fund report cards

Junto Capital Management LP

13F equity value
$4.7B
Positions
86
Top 10 concentration
26.6%
Quarters / total new picks
32 / 789
13F equity value over time
$0M$3B$5B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.9% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 62.5% of quarters (excess t = 0.73, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.0%
t-stat
0.73
Quarterly win rate
63%
Annualized excess
+0.4%
$1 → follow vs universe
$2.15 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.09420180630: follow 1.01520180930: follow 1.04520181231: follow 1.12820190331: follow 1.13020190630: follow 1.21720190930: follow 1.33520191231: follow 1.02720200331: follow 1.19320200630: follow 1.33820200930: follow 1.44320201231: follow 1.58620210331: follow 1.63920210630: follow 1.76220210930: follow 1.54420211231: follow 1.20920220331: follow 1.25720220630: follow 1.17920220930: follow 1.25820221231: follow 1.21020230331: follow 1.24820230630: follow 1.22620230930: follow 1.39220231231: follow 1.46620240331: follow 1.51320240630: follow 1.65520240930: follow 1.71620241231: follow 1.69320250331: follow 1.80820250630: follow 1.89120250930: follow 2.07520251231: follow 2.152 0.84 1.58 2.32 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 86 · 2026 Q1

Ticker Value Weight QoQ
TJX $156M
3.3%
ADD
BLK $155M
3.3%
TRIM
GWW $149M
3.2%
ADD
CSX $142M
3.0%
TRIM
ARMK $134M
2.9%
NEW
MAR $127M
2.7%
NEW
FFIV $102M
2.2%
ADD
RSP $98M
2.1%
NEW
PNC $97M
2.1%
NEW
MS $93M
2.0%
TRIM
PFGC $89M
1.9%
NEW
JBHT $83M
1.8%
NEW
YUM $80M
1.7%
TRIM
CFG $76M
1.6%
ADD
ON $75M
1.6%
NEW
AAPL $73M
1.5%
NEW
LPLA $72M
1.5%
ADD
WMT $71M
1.5%
NEW
SHW $70M
1.5%
NEW
AMZN $69M
1.5%
NEW

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.